Auswahl der wissenschaftlichen Literatur zum Thema „Ionic salts“

Pharmaceutical companies and FDA (Federal Drug Administration) rules rely heavily on crystalline active pharmaceutical ingredients delivered as tablets and powders in the form of neutral compounds, salts and solvates of neutral compounds and salts. About half of all drugs sold in the market are in the form of salts which are held together by ionic bonds along with some other forces. Recently, Ionic liquids (ILs) an interesting class of chemical compounds have offered potential opportunity for exploration as novel drug ionic liquid salts, particularly in the field of transdermal/topical drug delivery. Due to the multifunctional nature of these salts they could allow generation of new pathway to manipulate the transport and deposition behaviour of the drug molecule. It is this modular approach of IL that forms the basis of the research presented here, in which pharmaceutically acceptable compounds are combined with selected drugs with known problems. IL salts were generated by combining at least one drug molecule with FDA approved compounds and were assessed for physicochemical properties, skin deposition and permeation studies. Skin deposition data suggested that these systems exhibit high skin retention, which was found to correlate with the molecular weight. On the other hand, permeation data displayed an inverse relationship between flux values and molecular weight of the permeant. Similar work was extended with ILs with mixed anions containing two drugs. The benzalkonium-sulfacetamide ILs were investigated for synergism and the biological studies data display no synergistic effect. It was also illustrated that in-situ IL based ibuprofen hydrogels systems could be manipulated via IL approach for topical application. These findings suggest the potential applicability of IL based formulations for topical delivery of drugs.

This thesis, separated into Parts A and B, is a combination of work on two projects with overlapping themes. Both projects aimed to design an ionic liquid, or a salt system, to remove deleterious contaminants in the petroleum industry in a green and sustainable manner. In Part A, systematic studies have been conducted to design various salt systems that extract mercury via oxidative complexation, from natural gas and liquid hydrocarbon streams. These compounds were characterised using a wide range of analytical techniques. In the mercury extraction from the gas phase, a remarkable discovery of a custom-designed ionic liquid has led to the successful development of a commercial mercury scrubber (containing 15 tonnes of catalyst) at a PETRONAS Gas Processing Plant in Malaysia. In addition, cheaper binary inorganic systems have also been investigated. These were initially prepared as benchmarks to the ionic liquid systems, but have proved to be effective in their own right. This has (led to the development of a second generation of mercury scrubber, currently. under pilot scale evaluation. For mercury extraction from liquid hydrocarbons, again, two of the systems examined, namely the ionic liquids and binary inorganic salt systems, showed significant activity, and these systems are also currently under pilot scale evaluation. [n Part B, the aim was to develop a novel approach to remove C02 from natural gas streams using ionic liquids. Various ionic liquids were synthesised and characterised using various analytical techniques. Remarkably, these novel systems were found to absorb up to 1.5 mol CO2 per mol of ionic liquid, exceeding the best literature value of equimolar capacity, making them very attractive for further pilot scale testing.

Ionic liquid forming compounds often display low melting points (a lack of crystallisation at ambient temperature and pressure) due to decreased lattice energies in the crystalline state. The degree of anion-cation contact with respect to the type, strength and number of interactions is a major factor determining the lattice energies, melting point and general behaviour of ionic liquid forming salts. Intermolecular interactions between the anion and cation and the conformational states of each component of the salt are of interest since distinctive properties ascribed to ionic liquids are determined to a significant extent by these interactions. The direct insight into the spatial relationship between cation and anion provided by the analysis of crystal structures provides a basis from which features of the ionic liquid can be generally understood, since the short range order and interactions of related, non-crystalline compounds may be similar to those of the crystalline form. However, it is difficult to predict whether a particular ionic pair will produce a liquid at room temperature, due to numerous possible combinations of cations and anions and the subtleties of their interactions. Crystal engineering is the ability to assemble molecular or ionic components into the desired crystalline architecture by engineering a target network of supramolecular interactions known as synthons. In this investigation the problem of ionic liquid design is addressed using the concepts of crystal engineering in an inverse sense, the so-called anti crystal-engineering approach. A topical area in which the anti crystal-engineering concept may be of some value is that of Ionic Liquid Phases of Pharmaceutically Active Ions (Active Ionic Liquids). Thus, by using the knowledge gained of the intermolecular interactions, packing and ionic conformation which occur within ‘traditional’ ionic liquids, combined with the knowledge of which functional group combinations yield supramolecular synthons resulting in crystalline subjects, and the subsequent prevention thereof (anti crystal-engineering), appropriate ions shall be selected which may result in ionic liquid formation. The intermolecular interactions of a series of: • crystallised bis(trifluoromethanesulfonyl)amide (NTf2) and bis(methanesulfonyl)amide (NMes2) ionic liquids, • low melting N-alkyl-2-methyl-3-benzylimidazolium iodide salts with a range of alkyl chain lengths, from n=1 to 6 and including both n-butyl and s-butyl chains, • 1-methyl-1-propylpyrrolidinium chloride and, • a number of low melting salts containing trihalide and monohalide ions, in combination with typical IL organic cations namely, 1-ethyl-3-methylimidazolium, 1-ethyl-1-methylpyrrolidinium and 1-propyl-1-methylpyrrolidinium, were qualitatively investigated and/or compared using a combination of crystallographic, Hirshfeld surface and thermal analysis techniques. The NMes2 salts are known to exhibit higher glass transitions and higher viscosities than those of the NTf2 salts. The origins of these differences were analysed in terms of the importance of factors such as the C-H•••O hydrogen bond, fluorination, presence of an aromatic moiety and length of alkyl chain, using the Hirshfeld surfaces and their associated fingerprint plots. Additionally, the existence of C-F•••π and C-H•••π interactions were elucidated and the significance of anion-anion interactions was recognised. Thermal analysis of the N-alkyl-2-methyl-3-benzylimidazolium iodide salts revealed that the methyl- and (s-)butyl substituted salts have a significantly higher melting point than the rest of the series. Analysis of these crystal structures allowed examination of the influence of the substitutions on the different cation-anion and cation-cation interactions and thus the physical properties of the salts. Thermal analysis of the monohalide and trihalide salts revealed that the tribromide salts are lower melting than their monohalide analogues. Analysis of these crystal structures revealed the influence of the anions and the crystal packing on the physical properties of the salts. A series of crystalline and liquid salts were prepared from cations and anions drawn from Active Pharmaceutical Ingredients (APIs) and Generally Recognized As Safe (GRAS) materials. The solid-state structures of the crystalline salts were used as a basis for the anti-crystal engineering approach in the preparation of several “Active Ionic Liquids” (AILs). However, a side product also resulted during the synthetic route namely, methyl 9H-xanthene-9-carboxylate, a side product resulting from the API, propantheline. The results and methodology of the anti-crystal engineering procedure and the subsequent successful preparation and characterization of pharmaceutical ionic compounds are reported herein.